ASTEC LIFESCIENCES
ASTEC · NSE
581.05
-21.90 (-3.63%)
as of 29 Oct 2026 close
Open
598.00
High
606.95
Low
569.45
Prev close
602.95
52w high
941.75
26 Nov 2025
52w low
513.40
23 Mar 2026
VWAP
585.57
Delivery %
43.9%
of volume
Volume 74,478 · turnover ₹4.36 Cr · NSE bhavcopy (official close) · history since 04 Jan 2010
- ISIN
- INE563J01010
- Series
- EQ
- Listed on NSE
- 25 Nov 2009
- Face value
- ₹10
- F&O
- No
Source: NSE equity master · as of 30 Oct 2026
Daily · NSE EOD
Quarterly results · Standalone · latest 30 Sept 2026
filed 26 Oct 2026, 07:24 pm IST| ₹ crore | Sept 26* |
|---|---|
| Revenue | 72 |
| Other income | 1 |
| Total expenses | 110 |
| Operating margin | -27.5% |
| Finance costs | 7 |
| Depreciation | 11 |
| Profit before tax | -37 |
| Tax | -0 |
| Net profit | -37 |
| Net margin | -52.0% |
| EPS (₹) | -16.80 |
Source and definitions
NSE financial-results filings (XBRL / integrated filing). Figures exactly as filed with NSE in the company's results, converted to ₹ crore from the filing's own rounding. Operating margin = (PBT + finance costs + depreciation − other income) ÷ revenue. Net margin = net profit ÷ revenue. * = unaudited quarter. Consolidated figures are shown when the company files them; otherwise standalone.
Coming next in fundamentals
Arrives in Phase 2. Nothing here is estimated or filled in — we only show data we have.
- P/E, P/B, EV/EBITDA, ROE, ROCE (needs balance sheet + market cap)
- FII / DII / mutual fund split (from shareholding XBRL)
- Peer comparison